nodes	percent_of_prediction	percent_of_DWPC	metapath
Lubiprostone—CBR1—Doxorubicin—uterine cancer	0.701	1	CbGbCtD
Lubiprostone—CLCN2—artery—uterine cancer	0.0326	0.24	CbGeAlD
Lubiprostone—CLCN2—epithelium—uterine cancer	0.0124	0.091	CbGeAlD
Lubiprostone—CLCN2—smooth muscle tissue—uterine cancer	0.0119	0.0877	CbGeAlD
Lubiprostone—CLCN2—uterus—uterine cancer	0.0102	0.0752	CbGeAlD
Lubiprostone—CLCN2—female reproductive system—uterine cancer	0.0092	0.0676	CbGeAlD
Lubiprostone—CLCN2—vagina—uterine cancer	0.00832	0.0612	CbGeAlD
Lubiprostone—CBR1—myometrium—uterine cancer	0.00632	0.0465	CbGeAlD
Lubiprostone—CLCN2—lymph node—uterine cancer	0.00538	0.0396	CbGeAlD
Lubiprostone—CBR1—uterine cervix—uterine cancer	0.00492	0.0362	CbGeAlD
Lubiprostone—CBR1—decidua—uterine cancer	0.00469	0.0345	CbGeAlD
Lubiprostone—CBR1—renal system—uterine cancer	0.0046	0.0338	CbGeAlD
Lubiprostone—CBR1—endometrium—uterine cancer	0.00445	0.0327	CbGeAlD
Lubiprostone—CBR1—mammalian vulva—uterine cancer	0.0043	0.0317	CbGeAlD
Lubiprostone—CBR1—uterus—uterine cancer	0.0041	0.0302	CbGeAlD
Lubiprostone—CBR1—female reproductive system—uterine cancer	0.00369	0.0271	CbGeAlD
Lubiprostone—CBR1—female gonad—uterine cancer	0.00335	0.0247	CbGeAlD
Lubiprostone—CBR1—vagina—uterine cancer	0.00333	0.0245	CbGeAlD
Lubiprostone—Dinoprostone—CYP11A1—uterine cancer	0.00292	0.659	CrCbGaD
Lubiprostone—CBR1—lymph node—uterine cancer	0.00216	0.0159	CbGeAlD
Lubiprostone—Dinoprostone—CYP19A1—uterine cancer	0.00151	0.341	CrCbGaD
Lubiprostone—Syncope—Progesterone—uterine cancer	0.000818	0.00517	CcSEcCtD
Lubiprostone—Flatulence—Medroxyprogesterone Acetate—uterine cancer	0.000815	0.00515	CcSEcCtD
Lubiprostone—Dysgeusia—Medroxyprogesterone Acetate—uterine cancer	0.00081	0.00512	CcSEcCtD
Lubiprostone—Palpitations—Progesterone—uterine cancer	0.000806	0.0051	CcSEcCtD
Lubiprostone—Loss of consciousness—Progesterone—uterine cancer	0.000802	0.00507	CcSEcCtD
Lubiprostone—Cough—Progesterone—uterine cancer	0.000796	0.00503	CcSEcCtD
Lubiprostone—Muscle spasms—Medroxyprogesterone Acetate—uterine cancer	0.000795	0.00503	CcSEcCtD
Lubiprostone—Chest pain—Progesterone—uterine cancer	0.000777	0.00491	CcSEcCtD
Lubiprostone—Myalgia—Progesterone—uterine cancer	0.000777	0.00491	CcSEcCtD
Lubiprostone—Tremor—Medroxyprogesterone Acetate—uterine cancer	0.000775	0.0049	CcSEcCtD
Lubiprostone—Anxiety—Progesterone—uterine cancer	0.000774	0.00489	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Progesterone—uterine cancer	0.000771	0.00488	CcSEcCtD
Lubiprostone—Discomfort—Progesterone—uterine cancer	0.000767	0.00485	CcSEcCtD
Lubiprostone—Ill-defined disorder—Medroxyprogesterone Acetate—uterine cancer	0.000767	0.00485	CcSEcCtD
Lubiprostone—Dry mouth—Progesterone—uterine cancer	0.00076	0.0048	CcSEcCtD
Lubiprostone—Malaise—Medroxyprogesterone Acetate—uterine cancer	0.000746	0.00471	CcSEcCtD
Lubiprostone—Oedema—Progesterone—uterine cancer	0.000745	0.00471	CcSEcCtD
Lubiprostone—Syncope—Medroxyprogesterone Acetate—uterine cancer	0.000741	0.00469	CcSEcCtD
Lubiprostone—Shock—Progesterone—uterine cancer	0.000733	0.00463	CcSEcCtD
Lubiprostone—Palpitations—Medroxyprogesterone Acetate—uterine cancer	0.000731	0.00462	CcSEcCtD
Lubiprostone—Nervous system disorder—Progesterone—uterine cancer	0.00073	0.00462	CcSEcCtD
Lubiprostone—Tachycardia—Progesterone—uterine cancer	0.000727	0.00459	CcSEcCtD
Lubiprostone—Loss of consciousness—Medroxyprogesterone Acetate—uterine cancer	0.000727	0.00459	CcSEcCtD
Lubiprostone—Skin disorder—Progesterone—uterine cancer	0.000723	0.00457	CcSEcCtD
Lubiprostone—Hyperhidrosis—Progesterone—uterine cancer	0.00072	0.00455	CcSEcCtD
Lubiprostone—Anorexia—Progesterone—uterine cancer	0.00071	0.00449	CcSEcCtD
Lubiprostone—Chest pain—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.00445	CcSEcCtD
Lubiprostone—Myalgia—Medroxyprogesterone Acetate—uterine cancer	0.000704	0.00445	CcSEcCtD
Lubiprostone—Anxiety—Medroxyprogesterone Acetate—uterine cancer	0.000701	0.00443	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Medroxyprogesterone Acetate—uterine cancer	0.000699	0.00442	CcSEcCtD
Lubiprostone—Cramp muscle—Etoposide—uterine cancer	0.000698	0.00441	CcSEcCtD
Lubiprostone—Discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000695	0.0044	CcSEcCtD
Lubiprostone—Dry mouth—Medroxyprogesterone Acetate—uterine cancer	0.000688	0.00435	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Etoposide—uterine cancer	0.000684	0.00432	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Progesterone—uterine cancer	0.000678	0.00429	CcSEcCtD
Lubiprostone—Oedema—Medroxyprogesterone Acetate—uterine cancer	0.000675	0.00427	CcSEcCtD
Lubiprostone—Dyspnoea—Progesterone—uterine cancer	0.000664	0.0042	CcSEcCtD
Lubiprostone—Shock—Medroxyprogesterone Acetate—uterine cancer	0.000664	0.0042	CcSEcCtD
Lubiprostone—Rectal haemorrhage—Epirubicin—uterine cancer	0.000663	0.00419	CcSEcCtD
Lubiprostone—Nervous system disorder—Medroxyprogesterone Acetate—uterine cancer	0.000662	0.00418	CcSEcCtD
Lubiprostone—Tachycardia—Medroxyprogesterone Acetate—uterine cancer	0.000659	0.00416	CcSEcCtD
Lubiprostone—Dyspepsia—Progesterone—uterine cancer	0.000655	0.00414	CcSEcCtD
Lubiprostone—Skin disorder—Medroxyprogesterone Acetate—uterine cancer	0.000655	0.00414	CcSEcCtD
Lubiprostone—Hyperhidrosis—Medroxyprogesterone Acetate—uterine cancer	0.000652	0.00412	CcSEcCtD
Lubiprostone—Decreased appetite—Progesterone—uterine cancer	0.000647	0.00409	CcSEcCtD
Lubiprostone—Erythema—Dactinomycin—uterine cancer	0.000645	0.00408	CcSEcCtD
Lubiprostone—Anorexia—Medroxyprogesterone Acetate—uterine cancer	0.000643	0.00407	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Progesterone—uterine cancer	0.000643	0.00406	CcSEcCtD
Lubiprostone—Fatigue—Progesterone—uterine cancer	0.000642	0.00406	CcSEcCtD
Lubiprostone—Pain—Progesterone—uterine cancer	0.000637	0.00403	CcSEcCtD
Lubiprostone—Constipation—Progesterone—uterine cancer	0.000637	0.00403	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Medroxyprogesterone Acetate—uterine cancer	0.000615	0.00389	CcSEcCtD
Lubiprostone—Feeling abnormal—Progesterone—uterine cancer	0.000614	0.00388	CcSEcCtD
Lubiprostone—Rectal haemorrhage—Doxorubicin—uterine cancer	0.000613	0.00388	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Progesterone—uterine cancer	0.000609	0.00385	CcSEcCtD
Lubiprostone—Dyspnoea—Medroxyprogesterone Acetate—uterine cancer	0.000602	0.0038	CcSEcCtD
Lubiprostone—Ill-defined disorder—Dactinomycin—uterine cancer	0.000598	0.00378	CcSEcCtD
Lubiprostone—Dyspepsia—Medroxyprogesterone Acetate—uterine cancer	0.000594	0.00376	CcSEcCtD
Lubiprostone—Abdominal pain—Progesterone—uterine cancer	0.000589	0.00372	CcSEcCtD
Lubiprostone—Eructation—Epirubicin—uterine cancer	0.000588	0.00372	CcSEcCtD
Lubiprostone—Decreased appetite—Medroxyprogesterone Acetate—uterine cancer	0.000587	0.00371	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Medroxyprogesterone Acetate—uterine cancer	0.000583	0.00368	CcSEcCtD
Lubiprostone—Fatigue—Medroxyprogesterone Acetate—uterine cancer	0.000582	0.00368	CcSEcCtD
Lubiprostone—Malaise—Dactinomycin—uterine cancer	0.000582	0.00368	CcSEcCtD
Lubiprostone—Constipation—Medroxyprogesterone Acetate—uterine cancer	0.000577	0.00365	CcSEcCtD
Lubiprostone—Feeling abnormal—Medroxyprogesterone Acetate—uterine cancer	0.000556	0.00352	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Medroxyprogesterone Acetate—uterine cancer	0.000552	0.00349	CcSEcCtD
Lubiprostone—Myalgia—Dactinomycin—uterine cancer	0.000549	0.00347	CcSEcCtD
Lubiprostone—Hypersensitivity—Progesterone—uterine cancer	0.000549	0.00347	CcSEcCtD
Lubiprostone—Eructation—Doxorubicin—uterine cancer	0.000544	0.00344	CcSEcCtD
Lubiprostone—Discomfort—Dactinomycin—uterine cancer	0.000542	0.00343	CcSEcCtD
Lubiprostone—Asthenia—Progesterone—uterine cancer	0.000534	0.00338	CcSEcCtD
Lubiprostone—Abdominal pain—Medroxyprogesterone Acetate—uterine cancer	0.000533	0.00337	CcSEcCtD
Lubiprostone—Oedema—Dactinomycin—uterine cancer	0.000526	0.00333	CcSEcCtD
Lubiprostone—Diarrhoea—Progesterone—uterine cancer	0.000509	0.00322	CcSEcCtD
Lubiprostone—Anorexia—Dactinomycin—uterine cancer	0.000502	0.00317	CcSEcCtD
Lubiprostone—Hypersensitivity—Medroxyprogesterone Acetate—uterine cancer	0.000497	0.00314	CcSEcCtD
Lubiprostone—Dizziness—Progesterone—uterine cancer	0.000492	0.00311	CcSEcCtD
Lubiprostone—Asthenia—Medroxyprogesterone Acetate—uterine cancer	0.000484	0.00306	CcSEcCtD
Lubiprostone—Mediastinal disorder—Etoposide—uterine cancer	0.000483	0.00306	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Dactinomycin—uterine cancer	0.000479	0.00303	CcSEcCtD
Lubiprostone—Vomiting—Progesterone—uterine cancer	0.000473	0.00299	CcSEcCtD
Lubiprostone—Rash—Progesterone—uterine cancer	0.000469	0.00297	CcSEcCtD
Lubiprostone—Dermatitis—Progesterone—uterine cancer	0.000469	0.00297	CcSEcCtD
Lubiprostone—Headache—Progesterone—uterine cancer	0.000466	0.00295	CcSEcCtD
Lubiprostone—Diarrhoea—Medroxyprogesterone Acetate—uterine cancer	0.000462	0.00292	CcSEcCtD
Lubiprostone—Decreased appetite—Dactinomycin—uterine cancer	0.000457	0.00289	CcSEcCtD
Lubiprostone—Dysgeusia—Etoposide—uterine cancer	0.000457	0.00289	CcSEcCtD
Lubiprostone—Fatigue—Dactinomycin—uterine cancer	0.000454	0.00287	CcSEcCtD
Lubiprostone—Pain—Dactinomycin—uterine cancer	0.00045	0.00285	CcSEcCtD
Lubiprostone—Muscle spasms—Etoposide—uterine cancer	0.000449	0.00284	CcSEcCtD
Lubiprostone—Dizziness—Medroxyprogesterone Acetate—uterine cancer	0.000446	0.00282	CcSEcCtD
Lubiprostone—Lethargy—Epirubicin—uterine cancer	0.000443	0.0028	CcSEcCtD
Lubiprostone—Nausea—Progesterone—uterine cancer	0.000442	0.0028	CcSEcCtD
Lubiprostone—Feeling abnormal—Dactinomycin—uterine cancer	0.000434	0.00274	CcSEcCtD
Lubiprostone—Ill-defined disorder—Etoposide—uterine cancer	0.000433	0.00274	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Dactinomycin—uterine cancer	0.00043	0.00272	CcSEcCtD
Lubiprostone—Vomiting—Medroxyprogesterone Acetate—uterine cancer	0.000429	0.00271	CcSEcCtD
Lubiprostone—Rash—Medroxyprogesterone Acetate—uterine cancer	0.000425	0.00269	CcSEcCtD
Lubiprostone—Dermatitis—Medroxyprogesterone Acetate—uterine cancer	0.000425	0.00269	CcSEcCtD
Lubiprostone—Headache—Medroxyprogesterone Acetate—uterine cancer	0.000423	0.00267	CcSEcCtD
Lubiprostone—Malaise—Etoposide—uterine cancer	0.000421	0.00266	CcSEcCtD
Lubiprostone—Abdominal pain—Dactinomycin—uterine cancer	0.000416	0.00263	CcSEcCtD
Lubiprostone—Loss of consciousness—Etoposide—uterine cancer	0.00041	0.00259	CcSEcCtD
Lubiprostone—Lethargy—Doxorubicin—uterine cancer	0.00041	0.00259	CcSEcCtD
Lubiprostone—Cough—Etoposide—uterine cancer	0.000407	0.00258	CcSEcCtD
Lubiprostone—Nausea—Medroxyprogesterone Acetate—uterine cancer	0.000401	0.00253	CcSEcCtD
Lubiprostone—Chest pain—Etoposide—uterine cancer	0.000397	0.00251	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Etoposide—uterine cancer	0.000395	0.00249	CcSEcCtD
Lubiprostone—Discomfort—Etoposide—uterine cancer	0.000393	0.00248	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Epirubicin—uterine cancer	0.000391	0.00247	CcSEcCtD
Lubiprostone—Hypersensitivity—Dactinomycin—uterine cancer	0.000388	0.00245	CcSEcCtD
Lubiprostone—Gastritis—Epirubicin—uterine cancer	0.000384	0.00243	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Epirubicin—uterine cancer	0.000383	0.00242	CcSEcCtD
Lubiprostone—Abdominal distension—Epirubicin—uterine cancer	0.000378	0.00239	CcSEcCtD
Lubiprostone—Asthenia—Dactinomycin—uterine cancer	0.000378	0.00239	CcSEcCtD
Lubiprostone—Influenza—Epirubicin—uterine cancer	0.000375	0.00237	CcSEcCtD
Lubiprostone—Tachycardia—Etoposide—uterine cancer	0.000372	0.00235	CcSEcCtD
Lubiprostone—Skin disorder—Etoposide—uterine cancer	0.00037	0.00234	CcSEcCtD
Lubiprostone—Hyperhidrosis—Etoposide—uterine cancer	0.000368	0.00233	CcSEcCtD
Lubiprostone—Anorexia—Etoposide—uterine cancer	0.000363	0.0023	CcSEcCtD
Lubiprostone—Aspartate aminotransferase increased—Doxorubicin—uterine cancer	0.000362	0.00229	CcSEcCtD
Lubiprostone—Diarrhoea—Dactinomycin—uterine cancer	0.00036	0.00228	CcSEcCtD
Lubiprostone—Gastritis—Doxorubicin—uterine cancer	0.000356	0.00225	CcSEcCtD
Lubiprostone—Alanine aminotransferase increased—Doxorubicin—uterine cancer	0.000355	0.00224	CcSEcCtD
Lubiprostone—Abdominal distension—Doxorubicin—uterine cancer	0.00035	0.00221	CcSEcCtD
Lubiprostone—Influenza—Doxorubicin—uterine cancer	0.000347	0.0022	CcSEcCtD
Lubiprostone—Pollakiuria—Epirubicin—uterine cancer	0.000347	0.00219	CcSEcCtD
Lubiprostone—Weight increased—Epirubicin—uterine cancer	0.000342	0.00216	CcSEcCtD
Lubiprostone—Dyspnoea—Etoposide—uterine cancer	0.00034	0.00215	CcSEcCtD
Lubiprostone—Vomiting—Dactinomycin—uterine cancer	0.000335	0.00212	CcSEcCtD
Lubiprostone—Rash—Dactinomycin—uterine cancer	0.000332	0.0021	CcSEcCtD
Lubiprostone—Decreased appetite—Etoposide—uterine cancer	0.000331	0.00209	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Etoposide—uterine cancer	0.000329	0.00208	CcSEcCtD
Lubiprostone—Fatigue—Etoposide—uterine cancer	0.000328	0.00208	CcSEcCtD
Lubiprostone—Pain—Etoposide—uterine cancer	0.000326	0.00206	CcSEcCtD
Lubiprostone—Constipation—Etoposide—uterine cancer	0.000326	0.00206	CcSEcCtD
Lubiprostone—Urinary tract infection—Epirubicin—uterine cancer	0.000325	0.00206	CcSEcCtD
Lubiprostone—Pollakiuria—Doxorubicin—uterine cancer	0.000321	0.00203	CcSEcCtD
Lubiprostone—Weight increased—Doxorubicin—uterine cancer	0.000316	0.002	CcSEcCtD
Lubiprostone—Feeling abnormal—Etoposide—uterine cancer	0.000314	0.00198	CcSEcCtD
Lubiprostone—Nausea—Dactinomycin—uterine cancer	0.000313	0.00198	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Etoposide—uterine cancer	0.000311	0.00197	CcSEcCtD
Lubiprostone—Abdominal pain—Etoposide—uterine cancer	0.000301	0.0019	CcSEcCtD
Lubiprostone—Urinary tract infection—Doxorubicin—uterine cancer	0.000301	0.0019	CcSEcCtD
Lubiprostone—Oedema peripheral—Epirubicin—uterine cancer	0.000296	0.00187	CcSEcCtD
Lubiprostone—Connective tissue disorder—Epirubicin—uterine cancer	0.000295	0.00187	CcSEcCtD
Lubiprostone—Hypersensitivity—Etoposide—uterine cancer	0.000281	0.00177	CcSEcCtD
Lubiprostone—Oedema peripheral—Doxorubicin—uterine cancer	0.000274	0.00173	CcSEcCtD
Lubiprostone—Asthenia—Etoposide—uterine cancer	0.000273	0.00173	CcSEcCtD
Lubiprostone—Connective tissue disorder—Doxorubicin—uterine cancer	0.000273	0.00173	CcSEcCtD
Lubiprostone—Mediastinal disorder—Epirubicin—uterine cancer	0.000271	0.00171	CcSEcCtD
Lubiprostone—Mental disorder—Epirubicin—uterine cancer	0.000263	0.00166	CcSEcCtD
Lubiprostone—Malnutrition—Epirubicin—uterine cancer	0.000262	0.00165	CcSEcCtD
Lubiprostone—Erythema—Epirubicin—uterine cancer	0.000262	0.00165	CcSEcCtD
Lubiprostone—Diarrhoea—Etoposide—uterine cancer	0.000261	0.00165	CcSEcCtD
Lubiprostone—Flatulence—Epirubicin—uterine cancer	0.000258	0.00163	CcSEcCtD
Lubiprostone—Dysgeusia—Epirubicin—uterine cancer	0.000256	0.00162	CcSEcCtD
Lubiprostone—Dizziness—Etoposide—uterine cancer	0.000252	0.00159	CcSEcCtD
Lubiprostone—Muscle spasms—Epirubicin—uterine cancer	0.000252	0.00159	CcSEcCtD
Lubiprostone—Mediastinal disorder—Doxorubicin—uterine cancer	0.000251	0.00158	CcSEcCtD
Lubiprostone—Mental disorder—Doxorubicin—uterine cancer	0.000244	0.00154	CcSEcCtD
Lubiprostone—Ill-defined disorder—Epirubicin—uterine cancer	0.000243	0.00153	CcSEcCtD
Lubiprostone—Vomiting—Etoposide—uterine cancer	0.000242	0.00153	CcSEcCtD
Lubiprostone—Erythema—Doxorubicin—uterine cancer	0.000242	0.00153	CcSEcCtD
Lubiprostone—Malnutrition—Doxorubicin—uterine cancer	0.000242	0.00153	CcSEcCtD
Lubiprostone—Rash—Etoposide—uterine cancer	0.00024	0.00152	CcSEcCtD
Lubiprostone—Dermatitis—Etoposide—uterine cancer	0.00024	0.00152	CcSEcCtD
Lubiprostone—Headache—Etoposide—uterine cancer	0.000239	0.00151	CcSEcCtD
Lubiprostone—Flatulence—Doxorubicin—uterine cancer	0.000239	0.00151	CcSEcCtD
Lubiprostone—Dysgeusia—Doxorubicin—uterine cancer	0.000237	0.0015	CcSEcCtD
Lubiprostone—Malaise—Epirubicin—uterine cancer	0.000236	0.00149	CcSEcCtD
Lubiprostone—Syncope—Epirubicin—uterine cancer	0.000235	0.00148	CcSEcCtD
Lubiprostone—Muscle spasms—Doxorubicin—uterine cancer	0.000233	0.00147	CcSEcCtD
Lubiprostone—Palpitations—Epirubicin—uterine cancer	0.000231	0.00146	CcSEcCtD
Lubiprostone—Loss of consciousness—Epirubicin—uterine cancer	0.00023	0.00145	CcSEcCtD
Lubiprostone—Cough—Epirubicin—uterine cancer	0.000228	0.00144	CcSEcCtD
Lubiprostone—Nausea—Etoposide—uterine cancer	0.000226	0.00143	CcSEcCtD
Lubiprostone—Ill-defined disorder—Doxorubicin—uterine cancer	0.000225	0.00142	CcSEcCtD
Lubiprostone—Chest pain—Epirubicin—uterine cancer	0.000223	0.00141	CcSEcCtD
Lubiprostone—Myalgia—Epirubicin—uterine cancer	0.000223	0.00141	CcSEcCtD
Lubiprostone—Anxiety—Epirubicin—uterine cancer	0.000222	0.0014	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—uterine cancer	0.000221	0.0014	CcSEcCtD
Lubiprostone—Discomfort—Epirubicin—uterine cancer	0.00022	0.00139	CcSEcCtD
Lubiprostone—Malaise—Doxorubicin—uterine cancer	0.000218	0.00138	CcSEcCtD
Lubiprostone—Dry mouth—Epirubicin—uterine cancer	0.000218	0.00138	CcSEcCtD
Lubiprostone—Syncope—Doxorubicin—uterine cancer	0.000217	0.00137	CcSEcCtD
Lubiprostone—Palpitations—Doxorubicin—uterine cancer	0.000214	0.00135	CcSEcCtD
Lubiprostone—Oedema—Epirubicin—uterine cancer	0.000214	0.00135	CcSEcCtD
Lubiprostone—Loss of consciousness—Doxorubicin—uterine cancer	0.000213	0.00135	CcSEcCtD
Lubiprostone—Cough—Doxorubicin—uterine cancer	0.000211	0.00134	CcSEcCtD
Lubiprostone—Shock—Epirubicin—uterine cancer	0.00021	0.00133	CcSEcCtD
Lubiprostone—Nervous system disorder—Epirubicin—uterine cancer	0.000209	0.00132	CcSEcCtD
Lubiprostone—Tachycardia—Epirubicin—uterine cancer	0.000208	0.00132	CcSEcCtD
Lubiprostone—Skin disorder—Epirubicin—uterine cancer	0.000207	0.00131	CcSEcCtD
Lubiprostone—Hyperhidrosis—Epirubicin—uterine cancer	0.000206	0.00131	CcSEcCtD
Lubiprostone—Myalgia—Doxorubicin—uterine cancer	0.000206	0.0013	CcSEcCtD
Lubiprostone—Chest pain—Doxorubicin—uterine cancer	0.000206	0.0013	CcSEcCtD
Lubiprostone—Anxiety—Doxorubicin—uterine cancer	0.000205	0.0013	CcSEcCtD
Lubiprostone—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—uterine cancer	0.000205	0.00129	CcSEcCtD
Lubiprostone—Discomfort—Doxorubicin—uterine cancer	0.000204	0.00129	CcSEcCtD
Lubiprostone—Anorexia—Epirubicin—uterine cancer	0.000204	0.00129	CcSEcCtD
Lubiprostone—Dry mouth—Doxorubicin—uterine cancer	0.000202	0.00127	CcSEcCtD
Lubiprostone—Oedema—Doxorubicin—uterine cancer	0.000198	0.00125	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Epirubicin—uterine cancer	0.000195	0.00123	CcSEcCtD
Lubiprostone—Shock—Doxorubicin—uterine cancer	0.000194	0.00123	CcSEcCtD
Lubiprostone—Nervous system disorder—Doxorubicin—uterine cancer	0.000194	0.00122	CcSEcCtD
Lubiprostone—Tachycardia—Doxorubicin—uterine cancer	0.000193	0.00122	CcSEcCtD
Lubiprostone—Skin disorder—Doxorubicin—uterine cancer	0.000192	0.00121	CcSEcCtD
Lubiprostone—Hyperhidrosis—Doxorubicin—uterine cancer	0.000191	0.00121	CcSEcCtD
Lubiprostone—Dyspnoea—Epirubicin—uterine cancer	0.00019	0.0012	CcSEcCtD
Lubiprostone—Anorexia—Doxorubicin—uterine cancer	0.000188	0.00119	CcSEcCtD
Lubiprostone—Dyspepsia—Epirubicin—uterine cancer	0.000188	0.00119	CcSEcCtD
Lubiprostone—Decreased appetite—Epirubicin—uterine cancer	0.000186	0.00117	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Epirubicin—uterine cancer	0.000184	0.00117	CcSEcCtD
Lubiprostone—Fatigue—Epirubicin—uterine cancer	0.000184	0.00116	CcSEcCtD
Lubiprostone—Pain—Epirubicin—uterine cancer	0.000183	0.00115	CcSEcCtD
Lubiprostone—Constipation—Epirubicin—uterine cancer	0.000183	0.00115	CcSEcCtD
Lubiprostone—Musculoskeletal discomfort—Doxorubicin—uterine cancer	0.00018	0.00114	CcSEcCtD
Lubiprostone—Dyspnoea—Doxorubicin—uterine cancer	0.000176	0.00111	CcSEcCtD
Lubiprostone—Feeling abnormal—Epirubicin—uterine cancer	0.000176	0.00111	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Epirubicin—uterine cancer	0.000175	0.0011	CcSEcCtD
Lubiprostone—Dyspepsia—Doxorubicin—uterine cancer	0.000174	0.0011	CcSEcCtD
Lubiprostone—Decreased appetite—Doxorubicin—uterine cancer	0.000172	0.00109	CcSEcCtD
Lubiprostone—Gastrointestinal disorder—Doxorubicin—uterine cancer	0.000171	0.00108	CcSEcCtD
Lubiprostone—Fatigue—Doxorubicin—uterine cancer	0.00017	0.00108	CcSEcCtD
Lubiprostone—Constipation—Doxorubicin—uterine cancer	0.000169	0.00107	CcSEcCtD
Lubiprostone—Pain—Doxorubicin—uterine cancer	0.000169	0.00107	CcSEcCtD
Lubiprostone—Abdominal pain—Epirubicin—uterine cancer	0.000169	0.00107	CcSEcCtD
Lubiprostone—Feeling abnormal—Doxorubicin—uterine cancer	0.000163	0.00103	CcSEcCtD
Lubiprostone—Gastrointestinal pain—Doxorubicin—uterine cancer	0.000162	0.00102	CcSEcCtD
Lubiprostone—Hypersensitivity—Epirubicin—uterine cancer	0.000157	0.000995	CcSEcCtD
Lubiprostone—Abdominal pain—Doxorubicin—uterine cancer	0.000156	0.000987	CcSEcCtD
Lubiprostone—Asthenia—Epirubicin—uterine cancer	0.000153	0.000969	CcSEcCtD
Lubiprostone—Diarrhoea—Epirubicin—uterine cancer	0.000146	0.000924	CcSEcCtD
Lubiprostone—Hypersensitivity—Doxorubicin—uterine cancer	0.000146	0.00092	CcSEcCtD
Lubiprostone—Asthenia—Doxorubicin—uterine cancer	0.000142	0.000896	CcSEcCtD
Lubiprostone—Dizziness—Epirubicin—uterine cancer	0.000141	0.000893	CcSEcCtD
Lubiprostone—Vomiting—Epirubicin—uterine cancer	0.000136	0.000858	CcSEcCtD
Lubiprostone—Diarrhoea—Doxorubicin—uterine cancer	0.000135	0.000855	CcSEcCtD
Lubiprostone—Rash—Epirubicin—uterine cancer	0.000135	0.000851	CcSEcCtD
Lubiprostone—Dermatitis—Epirubicin—uterine cancer	0.000135	0.00085	CcSEcCtD
Lubiprostone—Headache—Epirubicin—uterine cancer	0.000134	0.000846	CcSEcCtD
Lubiprostone—Dizziness—Doxorubicin—uterine cancer	0.000131	0.000826	CcSEcCtD
Lubiprostone—Nausea—Epirubicin—uterine cancer	0.000127	0.000802	CcSEcCtD
Lubiprostone—Vomiting—Doxorubicin—uterine cancer	0.000126	0.000794	CcSEcCtD
Lubiprostone—Rash—Doxorubicin—uterine cancer	0.000125	0.000788	CcSEcCtD
Lubiprostone—Dermatitis—Doxorubicin—uterine cancer	0.000124	0.000787	CcSEcCtD
Lubiprostone—Headache—Doxorubicin—uterine cancer	0.000124	0.000783	CcSEcCtD
Lubiprostone—Nausea—Doxorubicin—uterine cancer	0.000117	0.000742	CcSEcCtD
